Biologic Agents May Reduce Risk of Mental Health Disorders in Some Patients with Psoriasis
Phase 2 Data Support Continued Evaluation of Mitapivat for Alpha, Beta Thalassemia
Intravitreal Injection Adherence Associated with Better VA During COVID-19 Pandemic